10.09.26 -- Evaluating The Levers Driving Productivity In Bioprocessing

Although polymer bags are an excellent choice for cold chain use, not all polymer films perform the same way, even if their specifications rate them for use at low temperatures.

See how a multiplex digital PCR approach enables accurate, reproducible VCN determination in gamma‑retrovirus–transduced CAR‑T cells, supporting streamlined workflows.

Compress your biologics process characterization timeline without sacrificing quality. Learn how FMEA, DoE, and platform approaches help you hit PPQ readiness faster while managing regulatory risk.

In this discussion, Dr. Alexis Santana explains what organoids are, how they are developed and applied, and why they are becoming a transformative tool in modern drug development.

The session highlights how tailored media solutions, combined with strong scientific understanding and scalable manufacturing practices, can support more efficient development.

Generate GMP-compliant mesenchymal stem cells (MSCs) at scale with a closed, automated workflow. Gain insight into how to optimize MSC harvest yields and ensure trilineage differentiation.

UV-protective single-use bags address a specific vulnerability in biopharmaceutical manufacturing, where UV exposure during production, storage, and cold chain logistics can compromise sensitive products.

Disconnected files, manual data handling, and missing rationale can weaken CMC handoffs. Take a look at where process knowledge commonly gets lost and how connected workflows can reduce rework.

Fruit fly genetics enables precise, scalable protein expression through stable integration, targeted control, inducible regulation, and heritable systems.

Discover how high-resolution ion mobility, pre-IMS fragmentation, and product ion analysis can resolve difficult peptide isomers and localize structural differences, supporting confident characterization.

Therapeutic peptide manufacturing depends on more than synthesis. Explore approaches for verifying raw materials, detecting difficult impurities, and confirming complex sequences with confidence.

Integrated analytics address multispecific antibody CMC challenges, accelerating timelines, reducing risk, and improving decisions through mechanism-driven bioassays, automation, and real-world case studies.

Delve into how to apply ICH Q2(R2) and Q14 to analytical procedures using QbD principles, ATP definition, and lifecycle management strategies to ensure regulatory alignment and product quality.

Despite challenges with mammalian host cell line diversity, examine mitigation strategies that drive efficiency and reproducibility, maximizing cell growth and product quality.